Vaxart, Inc. (VXRT) › Cash & EquivalentsVaxart, Inc. (VXRT) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-27: $106.44M2009-12-26: $59.51M2010-06-30: $89.80M2010-12-25: $53.56M2011-06-30: $74.20M2011-12-31: $94.31M2012-06-30: $53.80M2013-06-30: $66.80M2014-06-30: $81.70M2015-06-30: $44.70M2016-06-30: $49.70M2016-12-31: $8.40M2017-06-30: $17.70M2017-12-31: $1.57M2018-12-31: $11.51M2021-12-31: $143.75M2022-12-31: $44.01M2023-12-31: $34.76M$34.76M2008-12-27Cash & Equivalents (USD)2023-12-31Period endedCash & EquivalentsChange YoYSource filing2023-12-31$34.76M-21.0%2024-03-14Balance as of period end2022-12-31$44.01M-69.4%2024-03-14Balance as of period end2021-12-31$143.75M—2023-03-15Balance as of period end2018-12-31$11.51M+632.4%2019-02-06Balance as of period end2017-12-31$1.57M—2019-02-06Balance as of period end2017-06-30$17.70M—2017-09-01Balance as of period end2016-12-31$8.40M—2019-02-06Balance as of period end2016-06-30$49.70M+11.2%2017-09-01Balance as of period end2015-06-30$44.70M-45.3%2017-09-01Balance as of period end2014-06-30$81.70M+22.3%2016-09-13Balance as of period end2013-06-30$66.80M+24.2%2016-09-13Balance as of period end2012-06-30$53.80M—2015-09-11Balance as of period end2011-12-31$94.31M—2012-03-14Balance as of period end2011-06-30$74.20M—2014-09-30Balance as of period end2010-12-25$53.56M—2012-03-14Balance as of period end2010-06-30$89.80M—2013-09-27Balance as of period end2009-12-26$59.51M-44.1%2012-03-14Balance as of period end2008-12-27$106.44M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)